X5G-21382-35256
4 vaccinations
2 coded responses
36 check-ins
2 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 296 / SC
- Registered
- 2021-01-11
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-01-08
Dose 1 — Pfizer-BioNTech
-
2021-01-11
Registered in v-safe
- 2021-01-11
- 2021-01-12
- 2021-01-13
- 2021-01-14
- 2021-01-15
- 2021-01-22
-
2021-01-28
Dose 2 — Pfizer-BioNTech
- 2021-01-29
- 2021-01-30
- 2021-01-31
- 2021-02-01
- 2021-02-02
- 2021-02-03
- 2021-02-04
- 2021-02-11
- 2021-02-18
- 2021-02-25
- 2021-03-04
- 2021-03-11
- 2021-04-29
-
2021-07-29
Survey response — 6 months, dose 2MedDRA: Autoimmune hepatitis — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Autoimmune hepatitisMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-07-29
Report sent to call center — 6 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-08-02
-
2021-08-21
Dose 3 — Pfizer-BioNTech
-
2022-01-28
Survey response — 12 months, dose 2MedDRA: Autoimmune hepatitis, Breast cyst, Breast mass, Galactocele, Unevaluable event — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Symptoms: Autoimmune hepatitis, galactocele/cyst/mass in breast · Healthcare visit (other): Blood draws, ultrasound, biopsy and aspirationMedDRA releases: 2024-11 · check-in free text available
-
2022-01-28
Report sent to call center — 12 months, dose 2Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-01-31
-
2022-01-31
Call successfulParticipant prefers to complete VAERS report online
-
2022-04-21
Dose 4 — Moderna
- 2022-04-21
- 2022-04-22
- 2022-04-23
- 2022-04-24
- 2022-04-25
- 2022-04-26
- 2022-04-28
- 2022-05-05
- 2022-05-12
- 2022-05-19
- 2022-05-26
- 2022-06-02
- 2022-07-21
- 2022-10-20
- 2023-04-21
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-08 | Pfizer-BioNTech | |
| 2 | 2021-01-28 | Pfizer-BioNTech | |
| 3 | 2021-08-21 | Pfizer-BioNTech | No |
| 4 | 2022-04-21 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-07-29 | Successful | Participant prefers to complete VAERS report online |
| 2022-01-28 | Successful 2022-01-31 |
Participant prefers to complete VAERS report online |
Free text
Release 9 — 6 months, dose 2
Symptoms: Autoimmune hepatitis
Release 11 — 12 months, dose 2
Symptoms: Autoimmune hepatitis, galactocele/cyst/mass in breast
Healthcare visit (other): Blood draws, ultrasound, biopsy and aspiration
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Unevaluable event | · | · | ✓ |
| SD | Autoimmune hepatitis | ✓ | · | ✓ |
| SD | Breast cyst | · | · | ✓ |
| SD | Breast mass | · | · | ✓ |
| SD | Galactocele | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release